The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study

The Journal of Infectious Diseases
M J GlesbyA J Saah

Abstract

To determine if vaccination induces replication of human immunodeficiency virus type 1 (HIV-1), 42 HIV-1-infected subjects with CD4 cell counts of 200-500 cells/microL were randomized to receive influenza vaccine or saline placebo. Infectious cell-associated and plasma HIV-1 RNA virus load were measured twice at baseline and then at 7, 10, 14, and 30 days after injection by quantitative microculture and branched DNA amplification. The ratios of the geometric mean plasma HIV-1 load of the four follow-up visits compared with baseline in vaccine (n = 28) and placebo (n = 14) recipients were similar (1.05 [95% confidence interval, 0.80-1.37] for vaccine; 0.96 [95% confidence interval, 0.68-1.33] for placebo; P = .90). The geometric mean ratios of plasma virus load at each follow-up visit to baseline did not differ significantly from 1.0 for each group. Infectious cell-associated virus load measures yielded similar results. CD4 cell counts declined similarly in both groups at 6 months. Influenza vaccination did not increase HIV-1 load in this controlled clinical trial.

Citations

Dec 18, 2001·Journal of Medical Virology·A AmendolaA R Zanetti
Nov 30, 2000·Current Infectious Disease Reports·S A Tasker, M R Wallace
Mar 10, 2006·Current Infectious Disease Reports·Todd D GleesonSybil A Tasker
Nov 14, 1998·Disease-a-month : DM·H W HorowitzG P Wormser
Dec 13, 2002·Vaccine·Alessandro R ZanettiElisabetta Tanzi
Dec 2, 1999·Vaccine·M C RousseauJ Delmont
Apr 17, 2001·Infectious Disease Clinics of North America·G A Poland
Mar 15, 2003·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Daniel J Skiest, Timothy Machala
May 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A D FineK Fukuda
Jan 12, 2010·AIDS Research and Human Retroviruses·Adriana WeinbergMyron J Levin
Dec 28, 2000·AIDS·P S SullivanUNKNOWN Adult and Adolescent Spectrum of HIV Disease Investigators
Mar 11, 1998·The Pediatric Infectious Disease Journal·L B BrydakB Sikorska-Fic
Aug 5, 2000·The Pediatric Infectious Disease Journal·M KellerS J Chang
Apr 7, 2007·AIDS·David R Chadwick, Anna Maria Geretti
Jul 10, 2010·AIDS·Pablo TebasUNKNOWN Center for AIDS Research and Clinical Trials Unit of the University of Pennsylvania
Sep 29, 2004·American Journal of Nephrology·Sreedhar Mandayam, Tejinder S Ahuja
Oct 8, 2009·American Journal of Public Health·James D HeffelfingerAnthony Fiore
Jul 5, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·R Kandel, K L Hartshorn
Dec 15, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nancy F Crum-CianfloneTimothy Burgess
Dec 15, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Raphael Dolin
Dec 7, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lorry G Rubin Infectious Diseases Society of America
Feb 26, 1999·Leukemia & Lymphoma·L B Brydak, M Całbecka
Sep 4, 2012·Vaccine·M Jeffrey Mphahlele, Siyazi Mda
Mar 31, 2012·Enfermedades infecciosas y microbiología clínica·José López-AldeguerUNKNOWN GESIDA 6409 Study Group
Oct 19, 2007·La Revue de médecine interne·P Duchet NiedziolkaUNKNOWN pour le groupe GEVACCIM
Jan 11, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jiangfeng SunMichel J Tremblay
Jul 11, 1998·Infectious Disease Clinics of North America·M D Mileno, F J Bia
Sep 25, 2002·Clinics in Laboratory Medicine·Monique R FergusonWilliam A O'Brien
Feb 28, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Lidia B. BrydakBarbara Sikorska-Fic
Aug 26, 2016·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports·Lisa A GrohskopfJoseph S Bresee
Oct 2, 2004·The Journal of International Medical Research·G V ZuccottiE Riva
May 2, 2000·Hospital Medicine·C P Conlon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.